[Effect of thymalin and epithalamin on the metastasis of experimental tumors irradiated with pulsed laser radiation].
Moskalik. K G KG
Key Findings
- Thymalin/epithalamin enhanced the laser’s ability to prevent tumor spread in mice
- Treated mice showed more antibody‑producing cells in the spleen
- The peptide dose used was 1 mg per mouse, administered alongside laser exposure
Practical Outcomes
- The results hint that thymalin might have immune‑supporting effects when combined with specific laser therapy, but there’s no clear protocol for people to follow yet. More research in humans is needed before anyone should try this for health or anti‑cancer purposes.
Summary
In a mouse study, giving the peptide thymalin (and a similar one, epithalamin) together with a special laser treatment helped keep cancer from spreading and boosted certain immune cells, but the work was done only in lab animals and used a 1 mg dose that isn’t directly comparable to human use.
Abstract
The effect of thymalin and epithalamin on dissemination of tumors treated by pulsed laser radiation was studied in C57B1 female mice bearing subcutaneously transplanted melanoma B16 and Lewis carcinoma. Radiation was delivered from TOC-1001 neodymium laser, wave-length of 1,060 nm, pulse duration--1 msec and fluence--350-400 J/cm2. Drug dosage was 1 mg. Thymalin and epithalamin treatment potentiated the preventive effect of laser radiation on tumor dissemination. Application of the said agents was followed by an increase in antibody-producing cells (as measured by Jerne's procedure) in the spleen of irradiated melanoma B16--bearing mice.
Study Information
pubmed
1987